Stock Price Targets and Analyst Ratings All RatingsU.S.U.K.CanadianUpgradesDowngradesInitiationsPrice Target ChangesMore Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsBIIBBiogen Downgraded byBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingE. SeigermanSubscribe to MarketBeat All Access for the recommendation accuracy rating$146.47-0.6%$230.00 ➝ $164.00Outperform ➝ Market PerformCABACabaletta Bio Downgraded byEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingG. Clark-GartnerSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.38+3.0%$15.00 ➝ $6.00Outperform ➝ InlineEXELExelixis Downgraded byBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingE. DaroutSubscribe to MarketBeat All Access for the recommendation accuracy rating$33.29-1.2%$36.00 ➝ $40.00Outperform ➝ Market PerformHALHalliburton Downgraded byGriffin SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingK. SimpsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$25.97+0.8%Buy ➝ NeutralHOOKHookipa Pharma Downgraded byRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingB. AbrahamsSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.02-5.6%$48.00 ➝ $2.00Outperform ➝ Sector PerformHRHealthcare Realty Trust Downgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$16.88+1.1% $19.00Overweight ➝ NeutralDid You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. IIPRInnovative Industrial Properties Downgraded byCompass PointSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. RossSubscribe to MarketBeat All Access for the recommendation accuracy rating$73.66-22.7%$125.00 ➝ $78.00Buy ➝ NeutralIIPRInnovative Industrial Properties Downgraded byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$73.66-22.7%$118.00 ➝ $70.00Neutral ➝ UnderweightKIMKimco Realty Downgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$23.42+1.8% $26.00Overweight ➝ NeutralLAZLazard Downgraded byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingA. HallSubscribe to MarketBeat All Access for the recommendation accuracy rating$52.04+3.1%$65.00 ➝ $57.00Outperform ➝ Market PerformLENLennar Downgraded byBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. ReichardtSubscribe to MarketBeat All Access for the recommendation accuracy rating$138.08-0.2%Buy ➝ NeutralLINELineage Downgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$58.57+2.9%$78.00 ➝ $75.00Overweight ➝ NeutralLWLamb Weston Downgraded byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingT. PalmerSubscribe to MarketBeat All Access for the recommendation accuracy rating$62.09-0.7%$90.00 ➝ $68.00Buy ➝ NeutralMRKMerck & Co., Inc. Downgraded byBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingE. SeigermanSubscribe to MarketBeat All Access for the recommendation accuracy rating$98.05-1.5%$136.00 ➝ $105.00Outperform ➝ Market PerformNKENIKE Downgraded byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. FernandezSubscribe to MarketBeat All Access for the recommendation accuracy rating$76.94-0.2%$93.00 ➝ $80.00Outperform ➝ Market PerformORCLOracle Downgraded byMonness Crespi & HardtSubscribe to MarketBeat All Access for the recommendation accuracy ratingB. WhiteSubscribe to MarketBeat All Access for the recommendation accuracy rating$169.66+0.5% $130.00Neutral ➝ SellPBFPBF Energy Downgraded byTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. GabelmanSubscribe to MarketBeat All Access for the recommendation accuracy rating$25.15-1.2%$27.00 ➝ $20.00Hold ➝ SellRXSTRxSight Downgraded byStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy rating$33.66-11.9%$65.00 ➝ $40.00Buy ➝ HoldSLBSchlumberger Downgraded byGriffin SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingK. SimpsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$36.83-0.2%Buy ➝ NeutralSPROSpero Therapeutics Downgraded byEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy rating$0.96-4.3%$5.00 ➝ $5.00Outperform ➝ In-LineAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:36 AM ET. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
